Literature DB >> 15935869

Pharmaceutical applications of magnetic resonance imaging (MRI).

J Craig Richardson1, Richard W Bowtell, Karsten Mäder, Colin D Melia.   

Abstract

Magnetic resonance imaging (MRI) is a powerful imaging modality that provides internal images of materials and living organisms on a microscopic and macroscopic scale. It is non-invasive and non-destructive, and one of very few techniques that can observe internal events inside undisturbed specimens in situ. It is versatile, as a wide range of NMR modalities can be accessed, and 2D and 3D imaging can be undertaken. Despite widespread use and major advances in clinical MRI, it has seen limited application in the pharmaceutical sciences. In vitro studies have focussed on drug release mechanisms in polymeric delivery systems, but isolated studies of bioadhesion, tablet properties, and extrusion and mixing processes illustrate the wider potential. Perhaps the greatest potential however, lies in investigations of pharmaceuticals in vivo, where pilot human and animal studies have demonstrated we can obtain unique insights into the behaviour of gastrointestinal, topical, colloidal, and targeted drug delivery systems.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15935869     DOI: 10.1016/j.addr.2005.01.024

Source DB:  PubMed          Journal:  Adv Drug Deliv Rev        ISSN: 0169-409X            Impact factor:   15.470


  22 in total

1.  Real-time UV imaging of nicotine release from transdermal patch.

Authors:  Jesper Østergaard; Emil Meng-Lund; Susan Weng Larsen; Claus Larsen; Karsten Petersson; James Lenke; Henrik Jensen
Journal:  Pharm Res       Date:  2010-09-02       Impact factor: 4.200

2.  Novel application of MRI technique combined with flow-through cell dissolution apparatus as supportive discriminatory test for evaluation of controlled release formulations.

Authors:  Przemyslaw P Dorozyński; Piotr Kulinowski; Aleksander Mendyk; Anna Młynarczyk; Renata Jachowicz
Journal:  AAPS PharmSciTech       Date:  2010-03-30       Impact factor: 3.246

Review 3.  Strategies to improve drug delivery across the blood-brain barrier.

Authors:  Albertus G de Boer; Pieter J Gaillard
Journal:  Clin Pharmacokinet       Date:  2007       Impact factor: 6.447

4.  Amphiphilic hyperbranched fluoropolymers as nanoscopic 19F magnetic resonance imaging agent assemblies.

Authors:  Wenjun Du; Andreas M Nyström; Lei Zhang; Kenya T Powell; Yali Li; Chong Cheng; Samuel A Wickline; Karen L Wooley
Journal:  Biomacromolecules       Date:  2008-09-17       Impact factor: 6.988

5.  Synthesis and characterization of perfluoro-tert-butyl semifluorinated amphiphilic polymers and their potential application in hydrophobic drug delivery.

Authors:  Sarah Decato; Troy Bemis; Eric Madsen; Sandro Mecozzi
Journal:  Polym Chem       Date:  2014-11-21       Impact factor: 5.582

Review 6.  Application of UV Imaging in Formulation Development.

Authors:  Yu Sun; Jesper Østergaard
Journal:  Pharm Res       Date:  2016-10-20       Impact factor: 4.200

7.  A non-invasive, low-cost study design to determine the release profile of colon drug delivery systems: a feasibility study.

Authors:  Marina J M Maurer; Reinout C A Schellekens; Klaus D Wutzke; Gerard Dijkstra; Herman J Woerdenbag; Henderik W Frijlink; Jos G W Kosterink; Frans Stellaard
Journal:  Pharm Res       Date:  2012-03-16       Impact factor: 4.200

8.  Enteric coated magnetic HPMC capsules evaluated in human gastrointestinal tract by AC biosusceptometry.

Authors:  Luciana A Corá; Fernando G Romeiro; Fabiano C Paixão; Madileine F Américo; Ricardo B Oliveira; Oswaldo Baffa; José Ricardo A Miranda
Journal:  Pharm Res       Date:  2006-08       Impact factor: 4.200

9.  Ocular pharmacokinetic study using T₁ mapping and Gd-chelate- labeled polymers.

Authors:  Xianfeng Shi; Xin Liu; Xueming Wu; Zheng-Rong Lu; S Kevin Li; Eun-Kee Jeong
Journal:  Pharm Res       Date:  2011-06-21       Impact factor: 4.200

10.  Terahertz technology: a boon to tablet analysis.

Authors:  M P Wagh; Y H Sonawane; O U Joshi
Journal:  Indian J Pharm Sci       Date:  2009-05       Impact factor: 0.975

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.